Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8825 in painful diabetic polyneuropathy
NCT00508430Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Jul 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin enacarbil in diabetic polyneuropathy (DPN), sponsored by Astellas Pharma. Started Jul 2007; status: terminated.
02
Drugs
gabapentin enacarbil
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00508430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508430.